XML 44 R34.htm IDEA: XBRL DOCUMENT v3.25.3
Revenues Revenues (Tables)
 9 Months Ended
Sep. 30, 2025
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The Company’s revenues disaggregated by geography, based on the destination to which the Company ships its products, for the three and nine months ended September 30, 2025 and 2024 was as follows (in thousands):
 Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
United States$275,029 $226,326 $792,707 $654,150 
International79,656 74,713 225,573 224,947 
Total$354,685 $301,039 $1,018,280 $879,097 
The Company’s revenues disaggregated by product category for the three and nine months ended September 30, 2025 and 2024 was as follows (in thousands):
 Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
Thrombectomy$236,422 $204,141 $693,222 $595,346 
Embolization and Access118,263 96,898 325,058 283,751 
Total$354,685 $301,039 $1,018,280 $879,097 
Summary of Contract Assets
The following information summarizes the Company’s contract assets (in thousands):
September 30, 2025December 31, 2024
Contract assets$18,000 $18,000